Friess Associates LLC Elanco Animal Health Inc Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$25.62 - $34.96 $2.4 Million - $3.27 Million	-93,498 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $15.6 Million - $17.4 Million	-500,000 Reduced 84.25%	93,498 $3.16 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $5.33 Million - $6.03 Million	183,698 Added 44.83%	593,498 $19 Million
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $12 Million - $14 Million	404,800 Added 8096.0%	409,800 $12.9 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $170,500 - $180,950	5,000 New	5,000 $174,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.